TCI Wealth Advisors’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-95
Closed -$2.21K 1468
2023
Q1
$2.21K Hold
95
﹤0.01% 1943
2022
Q4
$1.38K Sell
95
-177
-65% -$3.3K ﹤0.01% 2052
2022
Q3
$5K Buy
272
+3
+1% +$69 ﹤0.01% 1488
2022
Q2
$5K Sell
269
-88
-25% -$1.83K ﹤0.01% 1512
2022
Q1
$9K Buy
357
+265
+288% +$6.78K ﹤0.01% 1171
2021
Q4
$3K Sell
92
-168
-65% -$4.87K ﹤0.01% 2015
2021
Q3
$8K Buy
260
+89
+52% +$2.96K ﹤0.01% 1270
2021
Q2
$5K Sell
171
-7
-4% -$202 ﹤0.01% 1459
2021
Q1
$5K Buy
178
+86
+93% +$2.44K ﹤0.01% 1277
2020
Q4
$2K Hold
92
﹤0.01% 1244
2020
Q3
$1K Hold
92
﹤0.01% 1372
2020
Q2
$1K Hold
92
﹤0.01% 1292
2020
Q1
$1K Buy
92
+66
+254% +$1.39K ﹤0.01% 1291
2019
Q4
$1K Hold
26
﹤0.01% 1386
2019
Q3
$1K Hold
26
﹤0.01% 1342
2019
Q2
$1K Sell
26
-50
-66% -$1.41K ﹤0.01% 1254
2019
Q1
$3K Hold
76
﹤0.01% 923
2018
Q4
$2K Buy
76
+51
+204% +$1.83K ﹤0.01% 1023
2018
Q3
$1K Hold
25
﹤0.01% 1276
2018
Q2
$1K Sell
25
-16
-39% -$540 ﹤0.01% 1336
2018
Q1
$1K Buy
41
+22
+116% +$744 ﹤0.01% 1184
2017
Q4
$1K Hold
19
﹤0.01% 1233
2017
Q3
$1K Buy
+19
New +$542 ﹤0.01% 1161

Other funds holding MYGN

TCI Wealth Advisors's MYGN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Myriad Genetics (MYGN) in Q2 2023, closing a stake of 95 shares — an estimated $2.21K sold.

TCI Wealth Advisors first reported a position in MYGN in Q3 2017 and held it in 23 quarters. The position peaked at $9K in Q1 2022. 188 funds tracked by Wall St. Rank hold MYGN as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Myriad Genetics position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 95 Myriad Genetics shares in Q2 2023, an estimated $2.21K.
  • TCI Wealth Advisors first reported a position in Myriad Genetics in Q3 2017 and held it in 23 quarters.
  • TCI Wealth Advisors's Myriad Genetics position peaked at $9K in Q1 2022.
  • 188 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.